Discovery of a New Genetic Mutation Enhancing the Effectiveness of Can..cer Immunotherapy Treatments

Researchers have identified a genetic mutation that slows the progression of melanoma and other cancers by boosting the immune system’s response.

According to a study published in the Journal of Experimental Medicine, this breakthrough could pave the way for new approaches to enhance existing immunotherapy treatments. The team, led by Dr. Hecheng Shi, an assistant professor at the University of North Texas Health Science Center, identified a gene named H2-Aa, which promotes tumor growth. However, disabling this gene in immune cells enhances resistance to tumors.

Experiments conducted on mice revealed that those with a modified H2-Aa gene showed greater resistance to tumor growth.

Furthermore, the use of a monoclonal antibody targeting this gene, combined with immunotherapy, significantly increased treatment effectiveness.

These promising results offer new hope for patients who do not respond to traditional immunotherapies and pave the way for future clinical trials to develop innovative treatments.

شاهد أيضا
تعليقات الزوار
Loading...